Drug intelligence / Profile preview

colesevelam + simvastatin

Development stage
Unknown
Lead developer
Daiichi Sankyo
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Small Molecules, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Oral
01

Overview

Colesevelam + simvastatin is a combination therapy used to lower elevated cholesterol levels, particularly low-density lipoprotein cholesterol (LDL-C), in patients with hypercholesterolemia. Colesevelam is a bile acid sequestrant that binds bile acids in the intestine, preventing their reabsorption and promoting increased clearance of LDL-C from the blood. Simvastatin is an HMG-CoA reductase inhibitor (statin) that blocks the rate-limiting step in cholesterol biosynthesis, leading to reduced hepatic cholesterol synthesis and increased uptake of LDL by upregulating hepatic LDL receptors. The combination provides additive reductions in LDL-C compared to either agent alone and is well tolerated. This therapy may be used when monotherapy does not achieve target lipid levels or when additional lowering of LDL-C is desired[1][5][8].

Brand names
WelcholCholestagelLodalis
Other names
colesevelam hydrochloride
02

Targets

HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)

Beyond the preview

Go deeper on colesevelam + simvastatin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on colesevelam + simvastatin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call